BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29121617)

  • 1. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
    Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
    J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.
    Chen H; Chen Z; Kuang Y; Li S; Zhang M; Liu J; Sun Z; Jiang B; Chen X; Li C
    Colloids Surf B Biointerfaces; 2018 Jul; 167():407-414. PubMed ID: 29704741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J; Du X; Zheng N; Xu L; Xu J; Li S
    Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
    Wong RCH; Ng DKP; Fong WP; Lo PC
    Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Chen K; Chang C; Liu Z; Zhou Y; Xu Q; Li C; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111166. PubMed ID: 32521461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-MnO
    Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
    Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
    Monem AS; Elbialy N; Mohamed N
    Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer.
    Wu X; Liu J; Yang L; Wang F
    Colloids Surf B Biointerfaces; 2019 Mar; 175():239-247. PubMed ID: 30540971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.
    Zhan J; Ma Z; Wang D; Li X; Li X; Le L; Kang A; Hu P; She L; Yang F
    Int J Nanomedicine; 2017; 12():2733-2748. PubMed ID: 28442903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
    Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
    Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles.
    Wang Y; Wang K; Yan X; Huang R
    Adv Healthc Mater; 2014 Apr; 3(4):485-9. PubMed ID: 23997032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-triggered liposomal cargo delivery platform incorporating photosensitizers and gold nanoparticles for enhanced singlet oxygen generation and increased cytotoxicity.
    Kautzka Z; Clement S; Goldys EM; Deng W
    Int J Nanomedicine; 2017; 12():969-977. PubMed ID: 28203076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging.
    Shu Y; Song R; Zheng A; Huang J; Chen M; Wang J
    Talanta; 2018 May; 181():278-285. PubMed ID: 29426513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.